Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

SELL
$0.36 - $0.63 $35 - $61
-98 Reduced 49.49%
100 $0
Q4 2022

Feb 10, 2023

BUY
$0.41 - $1.1 $80 - $216
197 Added 19700.0%
198 $0
Q3 2022

Nov 14, 2022

SELL
$0.57 - $1.77 $107 - $334
-189 Reduced 99.47%
1 $0
Q2 2022

Aug 12, 2022

SELL
$0.85 - $1.41 $61,196 - $101,514
-71,996 Reduced 99.74%
190 $0
Q1 2022

May 16, 2022

SELL
$1.16 - $2.5 $28,933 - $62,357
-24,943 Reduced 25.68%
72,186 $96,000
Q4 2021

Feb 08, 2022

BUY
$2.46 - $8.74 $143,678 - $510,468
58,406 Added 150.83%
97,129 $239,000
Q3 2021

Nov 15, 2021

BUY
$5.1 - $9.39 $54,503 - $100,350
10,687 Added 38.12%
38,723 $331,000
Q2 2021

Sep 13, 2021

BUY
$3.95 - $6.88 $110,742 - $192,887
28,036 New
28,036 $179,000

Others Institutions Holding PAVM

# of Institutions
1
Shares Held
2.24M
Call Options Held
0
Put Options Held
0

About PAVmed Inc.


  • Ticker PAVM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 90,999,104
  • Market Cap $74.6M
  • Description
  • PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...
More about PAVM
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.